Inhibition of Glutamate-induced Nitric Oxide Synthase Activation by Dopamine in Cultured Rat Retinal Neurons
Overview
Authors
Affiliations
Previously, we showed that dopamine protects cultured retinal neurons from N-methyl-D-aspartate (NMDA) receptor mediated-glutamate excitotoxicity via dopamine D1 receptor. This study has demonstrated for the first time that nitric oxide synthase (NOS) plays a crucial role in dopamine-induced neuroprotection. Our patch clamp study has shown that dopamine does not affect the NMDA-induced whole cell current. Dopamine or SKF38393 (D1 receptor agonist) inhibited ionomycin (calcium ionophore)-induced toxicity, while dopamine did not affect S-nitrosocysteine (NO donor)-induced toxicity. Biochemical analysis on enzymatic activities has shown that dopamine or cAMP (which is generated through D1 receptor stimulation) inhibits glutamate induced-NOS activation. These results suggest that dopamine inhibits glutamate induced-NOS activation via D1 receptor, resulting in the protection of retinal neurons.
Caravaggio F, Scifo E, Sibille E, Hernandez-Da Mota S, Gerretsen P, Remington G Exp Eye Res. 2018; 175:32-41.
PMID: 29883636 PMC: 6167174. DOI: 10.1016/j.exer.2018.06.006.
Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes.
Aung M, Park H, Han M, Obertone T, Abey J, Aseem F J Neurosci. 2014; 34(3):726-36.
PMID: 24431431 PMC: 3891954. DOI: 10.1523/JNEUROSCI.3483-13.2014.
Li G, Li T, Fan B, Zheng Y, Ma T Mol Vis. 2012; 18:2882-95.
PMID: 23233790 PMC: 3519376.
Meng S, Ryu S, Zhao B, Zhang D, Driever W, McMahon D Mol Vis. 2008; 14:2475-83.
PMID: 19112533 PMC: 2610293.